Business Development Director, Advanced Therapies (Cell and Gene Therapy) (Fully Remote)

FUJIFILM Biotechnologies; United States; Remote; USD 150,000 - 230,000; Full time

Job summary

FUJIFILM Biotechnologies is seeking a results-driven sales leader to own net-new revenue for Advanced Therapies within a defined territory. You will lead complex, consultative sales cycles across multi-stakeholder teams to advance opportunities from discovery through signature.

In this role you will shape and negotiate contracts that reflect value and risk, build a dominant regional pipeline, and collaborate with cross-functional partners to accelerate adoption of cutting-edge therapies.

Responsibilities

• Own net-new revenue for Advanced Therapies in your territory.
• Lead complex, consultative sales cycles across multi-stakeholder teams.
• Shape and negotiate contracts aligned with value and risk.
• Own a strategic region and build a dominant pipeline.
• Orchestrate from first meeting to signature with cross-functional partners.

Job description

• Own net-new revenue for Advanced Therapies in your territory.
• Lead complex, consultative sales cycles across multi-stakeholder teams.
• Shape and negotiate contracts aligned with value and risk.

Why this role matters:

• Fuel growth where science meets scale by expanding the Advanced Therapies portfolio.
• Own a strategic region and build a dominant pipeline.
• Orchestrate from first meeting to signature with cross-functional partners.

Our culture and values:

• Patient-first impact driven by improving patient outcomes.
• Integrity and quality in GMP-regulated environments.
• Respect and inclusion with diverse perspectives.

FUJIFILM Biotechnologies

FUJIFILM Biotechnologies develops and manufactures advanced therapies, including cell and gene therapies, vaccines, and biologics in partnership with innovative biopharma companies. With over 70,000 employees globally through its parent company Fujifilm, the organization fosters a culture of passion, energy, and drive called 'Genki'.